AI assistant
Forte Biosciences, Inc. — Director's Dealing 2021
Apr 13, 2021
33769_dirs_2021-04-13_f79ba0d4-c08b-4a3d-a485-cb10410b8890.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Forte Biosciences, Inc. (FBRX)
CIK: 0001419041
Period of Report: 2021-04-09
Reporting Person: Riley Antony A (Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-04-09 | Stock Option (right to buy) | $39.66 | A | 42500 | Acquired | 2031-04-09 | Common Stock (42500) | Direct |
Footnotes
F1: Subject to the Reporting Person's Continuous Service (as defined in the 2017 Equity Incentive Plan) through each applicable vesting date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the total shares subject to the option shall vest every month thereafter such that all shares shall be fully vested on the four year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean April 9, 2021.